Revefenacin Trihydrate is used to treat Chronic Obstructive Pulmonary Disease (COPD). It is a long-acting muscarinic antagonist (LAMA) designed for once-daily inhalation therapy. It is grouped under the following drug class(es): Bronchodilators. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include CB9J2CKN88. Its PubChem CID is 171390019.
Revefenacin trihydrate
| CAS No | N/A |
|---|---|
| Molecular Formula | C35H49N5O7 |
| Molecular Weight | 651.8 g/mol |
| Synonyms | [1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate;trihydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Revefenacin Trihydrate is used to treat Chronic Obstructive Pulmonary Disease (COPD). It is a long-acting muscarinic antagonist (LAMA) designed for once-daily inhalation therapy.
The listed CAS number is N/A.
The listed molecular formula is C35H49N5O7.
The listed molecular weight is 651.8 g/mol.
[1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate;trihydrate.
The source lists CB9J2CKN88.